Jamal Anouar, Draoui Najat, Assarrar Imane, Rouf Siham, Latrech Hanane
Department of Endocrinology-Diabetology-Nutrition, Mohammed VI University Hospital, Medical School, Mohamed the First University, Oujda, Morocco.
Department of Endocrinology-Diabetology-Nutrition, Mohammed VI University Hospital, Medical School, Mohamed the First University, Oujda, Morocco; Laboratory of Epidemiology, Clinical Research and Public Health, Medical School, Mohamed the First University, Oujda, Morocco.
Int J Surg Case Rep. 2024 Jul;120:109874. doi: 10.1016/j.ijscr.2024.109874. Epub 2024 Jun 6.
Ectopic pituitary neuroendocrine tumor (EPNET) is a very rare entity, seldom with apoplexy evolution. Only three cases of intracranial ectropic pituitary neuroendocrine tumor apoplexy were reported in the literature.
We report the case of a 45-year-old woman with a history of amenorrhea, and headaches. Neuroimaging showed a very aggressive giant mass within the clivus with the invasion of the sphenoidal sinus and encasement of internal carotid arteries with an empty sella. Endocrinology work-up revealed an exceedingly high level of prolactin surprisingly without galactorrhea. Immunohistochemical analysis after an endonasal biopsy confirmed the diagnosis of prolactinoma. One month after Cabergoline initiation, an apoplexy of the ectopic pituitary neuroendocrine tumor occurred. Conservational management with a decrease in cabergoline dose was performed.
This article highlights data from various cases reported in the literature in addition to our case to confirm the extreme rarity of apoplexy as a complication of EPNET.
Pituitary apoplexy in ectopic pituitary neuroendocrine tumor is extremely rare. Therefore, in case of unusual localization of pituitary neuroendocrine tumor, a thorough follow-up is necessary to detect complications and ensure early management.
异位垂体神经内分泌肿瘤(EPNET)是一种非常罕见的疾病,很少发生卒中样演变。文献中仅报道了3例颅内异位垂体神经内分泌肿瘤卒中。
我们报告了一例45岁女性,有闭经和头痛病史。神经影像学检查显示斜坡内有一个极具侵袭性的巨大肿块,侵犯蝶窦并包绕颈内动脉,伴有空蝶鞍。内分泌检查发现催乳素水平极高,令人惊讶的是没有溢乳。经鼻活检后的免疫组织化学分析确诊为催乳素瘤。开始使用卡麦角林治疗1个月后,异位垂体神经内分泌肿瘤发生卒中。采取了降低卡麦角林剂量的保守治疗措施。
本文除了介绍我们的病例外,还重点阐述了文献中报道的各种病例数据,以证实卒中作为EPNET并发症极其罕见。
异位垂体神经内分泌肿瘤发生垂体卒中极为罕见。因此,对于垂体神经内分泌肿瘤定位异常的病例,有必要进行全面随访以发现并发症并确保早期治疗。